You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康辰藥業(603590.SH):收購密蓋息資產獲得備案
格隆匯 07-08 15:39

格隆匯7月8日丨康辰藥業(603590.SH)公佈,公司此前審議通過了關於支付現金收購資產相關議案。公司擬通過二級全資子公司上海康辰以支付現金的方式收購經過業務重組後的泰凌醫藥國際有限公司100%股權,以實現對密蓋息資產的收購。

收購完成後,泰凌醫藥(01011.HK)的下屬子公司泰凌醫藥(亞洲)有限公司對公司全資子公司康辰生物(上海康辰的股東)進行增資,最終持有康辰生物增資後40%的股權。

近日,公司收到中國(上海)自由貿易試驗區管理委員會出具的《境外投資項目備案通知書》(滬自貿管境外備[2020]49號)和《企業境外投資證書》(境外投資證第N3109202000079號)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account